Haemophagocytic syndrome with disseminated intravascular coagulation associated with tuberculosis
- PMID: 23456163
- PMCID: PMC3618848
- DOI: 10.1136/bcr-2013-008743
Haemophagocytic syndrome with disseminated intravascular coagulation associated with tuberculosis
Abstract
Haemophagocytic syndrome (HPS) is a clinical entity that combines non-specific clinical and biological features. The diagnosis is usually confirmed by a bone marrow examination. HPS may be primary or secondary to a malignancy or to an infectious or autoimmune disease. Early aggressive survey of the aetiology and optimal treatment of the underlying disease improve the outcome of life-threatening HPS. Infection-associated HPS occurs predominantly in immunocompromised patients and is usually fatal. Leading trigger agents are viruses, especially the Epstein-Barr virus and cytomegalovirus. Mycobacterial infections associated with HPS are rare but should be considered in those patients where there is associated fever of unknown origin. We present a case of disseminated tuberculosis-associated HPS.
Figures
References
-
- Glasser RM, Walker RI, Herion JC. The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med 1970;125:691–5 - PubMed
-
- Fujita M, Kunitake R, Nagano Y, et al. Disseminated intravascular coagulation associated with pulmonary tuberculosis. Intern Med 1997;36:218–20 - PubMed
-
- Brastianos PK, Swanson JW, Torbenson M, et al. Tuberculosis-associated hemophagocytic syndrome. Lancet Infect Dis 2006;6:447–54 - PubMed
-
- Lee SW, Wang CY, Lee BJ, et al. Hemophagocytic syndrome in miliary tuberculosis presenting with noncaseating granulomas in bone marrow and liver. J Formos Med Assoc 2008;107:495–9 - PubMed
-
- Larroche C. Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment. Joint Bone Spine 2012;79:356–61 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical